long-term effects of glp-1 medications New Research on GLP-1s & Bone Health 🦴 ​A new large-scale study has raised questions about the receptor agonists (like Ozempic and Wegovy). While these are revolutionary glp-1 long term effects The

Implications for employers: The White House press release and news reports remain vague about pricing for employer sponsored health plans - so employers should watch closely to see the impact on their acquisition costs

Impact of obesity on remission and disease activity in rheumatoid arthritis: a systematic review and meta-analysis

These GLP-1 medications, like Ozempic, Wegovy, and Mounjaro, were originally designed to treat diabetes

GLP-1 Receptor agonist market Size report, 20202027

Exogenous administration of amylin consistently reduced food intake and body weight, 18-21 whereas amylin-knockout mice exhibited increased adiposity and impaired glycemic regulation, confirming its role in appetite and energy balance